Blockade of stress-induced increase of glutamate release in the rat prefrontal/frontal cortex by agomelatine involves synergy between melatonergic and 5-HT2C receptor-dependent pathways

BMC Neuroscience

Volumn 11, Issue , 2010, Pages

  Tardito, Daniela ^a   Milanese, Marco ^b   Bonifacino, Tiziana ^b   Musazzi, Laura ^a   Grilli, Massimo ^b   Mallei, Alessandra ^a   Mocaer, Elisabeth ^c   Gabriel Gracia, Cecilia ^c   Racagni, Giorgio ^a,d   Popoli, Maurizio ^a   Bonanno, Giambattista ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

^d IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; AGOMELATINE; ANTIDEPRESSANT AGENT; GLUTAMIC ACID; MELATONIN; MELATONIN 1 RECEPTOR; MELATONIN 2 RECEPTOR; S 32006; SEROTONIN 2C ANTAGONIST; SEROTONIN 2C RECEPTOR; UNCLASSIFIED DRUG; ACETAMIDE DERIVATIVE; CENTRAL DEPRESSANT AGENT; INDOLE DERIVATIVE; MELATONIN RECEPTOR; PYRIDINE DERIVATIVE; S32006;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BRAIN SYNAPTOSOME; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DEPOLARIZATION; ENZYME RELEASE; FOOTSHOCK; FRONTAL CORTEX; NONHUMAN; PREFRONTAL CORTEX; RAT; ANALYSIS OF VARIANCE; ANIMAL; DRUG EFFECT; DRUG POTENTIATION; ELECTRIC SHOCK; FRONTAL LOBE; METABOLISM; PHYSIOLOGICAL STRESS; PHYSIOLOGY; SYNAPTOSOME;

ACETAMIDES; ANALYSIS OF VARIANCE; ANIMALS; CENTRAL NERVOUS SYSTEM DEPRESSANTS; ELECTROSHOCK; FRONTAL LOBE; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; INDOLES; MELATONIN; PYRIDINES; RATS; RECEPTOR, SEROTONIN, 5-HT2C; RECEPTORS, MELATONIN; STRESS, PHYSIOLOGICAL; SYNAPTOSOMES;

EID: 77952994867     PISSN: None     EISSN: 14712202     Source Type: Journal    
DOI: 10.1186/1471-2202-11-68     Document Type: Article

References (36)

1. Anderson IM. Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability. J Affect Disord 2000, 58:19-36. 10.1016/S0165-0327(99)00092-0, 10760555.
2. Danish University Antidepressant Group Paroxetine: a selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter study. Danish University Antidepressant Group. J Affect Disord 1990, 18:289-99. 10.1016/0165-0327(90)90081-I, 2140382, Danish University Antidepressant Group.
3. Sonawalla SB, Fava M. Severe depression: is there a best approach?. CNS Drugs 2001, 15:765-76. 10.2165/00023210-200115100-00003, 11602003.
4. Vestergaard P, Gram LF, Kragh-Sorensen P, Bech P, Reisby N, Bolwig TG. Therapeutic potentials of recently introduced antidepressants. Danish University Antidepressant Group. Psychopharmacol Ser 1993, 10:190-198.
5. Kupfer DJ. Sleep research in depressive illness: clinical implications--a tasting menu. Biol Psychiatry 1995, 38:391-403. 10.1016/0006-3223(94)00295-E, 8547459.
6. Lopes MS, Quera-Salva MA, Guilleminault C. Non-REM sleep instability in patients with major depressive disorder: subjective improvement and improvement of non-REM sleep instability with treatment (Agomelatine). Sleep Medicine 2007, 9:34-41.
7. Lam RW. Sleep disturbances and depression: a challenge for antidepressants. Int Clin Psychopharmacol 2006, 21(Suppl 1):S25-S29. 10.1097/01.yic.0000195658.91524.61, 16436937.
8. Souetre E, Salvati E, Wehr TA, Sack DA, Krebs B, Darcourt G. Twenty-four-hour profiles of body temperature and plasma TSH in bipolar patients during depression and during remission and in normal control subjects. Am J Psychiatry 1998, 145:1133-1137.
9. Tsuno N, Besset A, Ritchie K. Sleep and depression. J Clin Psychiatry 2005, 66:1254-1269. 10.4088/JCP.v66n1008, 16259539.
10. Van CE, Turek FW. Depression: a disorder of timekeeping?. Perspect Biol Med 1986, 29:510-519.
11. Wirz-Justice A. Biological rhythm disturbances in mood disorders. Int Clin Psychopharmacol 2006, 21(Suppl 1):S11-S15. 10.1097/01.yic.0000195660.37267.cf, 16436934.
12. Audinot V, Mailliet F, Lahaye-Brasseur C, Bonnaud A, Le Gall A, Amosse C, Dromaint S, Rodriguez M, Nagel N, Galizzi JP, Malpaux B, Guillaumet G, Lesieur D, Lefoulon F, Renard P, Delagrange P, Boutin JA. New selective ligands of human cloned melatonin MT1 and MT2 receptors. Naunyn Schmiedebergs Arch Pharmacol 2003, 367:553-561. 10.1007/s00210-003-0751-2, 12764576.
13. Millan MJ, Gobert A, Lejeune F, Dekeyne A, Newman-Tancredi A, Pasteau V, Rivet JM, Cussac D. The novel melatonin agonist agomelatine (S20098) is an antagonist at 5-hydroxytryptamine2C receptors, blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathways. J Pharmacol Exp Ther 2003, 306:954-964. 10.1124/jpet.103.051797, 12750432.
14. Bertaina-Anglade V, la Rochelle CD, Boyer PA, Mocaer E. Antidepressant-like effects of agomelatine (S 20098) in the learned helplessness model. Behav Pharmacol 2006, 17:703-713. 10.1097/FBP.0b013e3280116e5c, 17110796.
15. Bourin M, Mocaer E, Porsolt R. Antidepressant-like activity of S 20098 (agomelatine) in the forced swimming test in rodents: involvement of melatonin and serotonin receptors. J Psychiatry Neurosci 2004, 29:126-133. 383344, 15069466.
16. Barden N, Shink E, Labbe M, Vacher R, Rochford J, Mocaer E. Antidepressant action of agomelatine (S 20098) in a transgenic mouse model. Prog Neuropsychopharmacol Biol Psychiatry 2005, 29:908-916. 10.1016/j.pnpbp.2005.04.032, 16005135.
17. Papp M, Gruca P, Boyer PA, Mocaer E. Effect of agomelatine in the chronic mild stress model of depression in the rat. Neuropsychopharmacol 2003, 28:694-703.
18. Goodwin GM, Emsley R, Rembry S, Rouillon F. Agomelatine prevents relapse in patients with major depressive disorder without evidence of a discontinuation syndrome: a 24-week randomized, double-blind, placebo-controlled trial. J Clin Psychiatry 2009, 70:1128-37. 10.4088/JCP.08m04548, 19689920.
19. Loo H, Hale A, D'Haenen H. Determination of the dose of agomelatine, a melatoninergic agonist and selective 5-HT(2C) antagonist, in the treatment of major depressive disorder: a placebo-controlled dose range study. Int Clin Psychopharmacol 2002, 17:239-247. 10.1097/00004850-200209000-00004, 12177586.
20. Kennedy SH, Emsley R. Placebo-controlled trial of agomelatine in the treatment of major depressive disorder. Eur Neuropsychopharmacol 2006, 16:93-100. 10.1016/j.euroneuro.2005.09.002, 16249073.
21. Olié JP, Kasper S. Efficacy of agomelatine, a MT1/MT2 receptor agonist with 5-HT2C antagonistic properties, in major depressive disorder. Int J Neuropsychopharmacol 2007, 10:661-673.
22. Bonanno G, Giambelli R, Raiteri L, Tiraboschi E, Zappettini S, Musazzi L, Raiteri M, Racagni G, Popoli M. Chronic antidepressants reduce depolarization-evoked glutamate release and protein interactions favoring formation of SNARE complex in hippocampus. J Neurosci 2005, 25:3270-3279. 10.1523/JNEUROSCI.5033-04.2005, 15800181.
23. Michael-Titus AT, Bains S, Jeetle J, Whelpton R. Imipramine and phenelzine decrease glutamate overflow in the prefrontal cortex--a possible mechanism of neuroprotection in major depression?. Neuroscience 2000, 100:681-684. 10.1016/S0306-4522(00)00390-0, 11036201.
24. Tokarski K, Bobula B, Wabno J, Hess G. Repeated administration of imipramine attenuates glutamatergic transmission in rat frontal cortex. Neuroscience 2008, 153:789-795. 10.1016/j.neuroscience.2008.03.007, 18403127.
25. Popoli M, Musazzi L, Barbiero VS, Zappettini S, Mocaër E, Gabriel C, Mallei A, Milanese M, Giambelli R, Bonanno G, Racagni G. The novel antidepressant agomelatine reduces the release of glutamate induced by acute footshock stress in synaptosomes of prefrontal/frontal cortex. Int J Neuropsychopharmacol 2008, Suppl 1:P-01.100.
26. Musazzi L, Milanese M, Barbiero VS, Zappettini S, Tardito D, Farisello P, Bonifacino T, Mallei A, Baldelli P, Racagni G, Raiteri M, Benfenati F, Bonanno G, Popoli M. Acute stress increases depolarization-evoked glutamate release in the rat prefrontal/frontal cortex: the dampening action of antidepressants. PloS ONE 2010, 5(1):e8566. 10.1371/journal.pone.0008566, 2797327, 20052403.
27. Raiteri M, Marchi M, Maura G. Chronic drug treatments induce changes in the sensitivity of presynaptic autoreceptors but not of presynaptic heteroreceptors. Eur J Pharmacol 1983, 91:141-143. 10.1016/0014-2999(83)90377-1, 6311569.
28. Pittaluga A, Raiteri L, Longordo F, Luccini E, Barbiero VS, Racagni G, Popoli M, Raiteri M. Antidepressant treatments and function of glutamate ionotropic receptors mediating amine release in hippocampus. Neuropharmacol 2007, 53:27-36.
29. Soumier A, Banasr M, Lortet S, Masmejean F, Bernard N, Kerkerian-Le-Goff L, Gabriel C, Millan MJ, Mocaer E, Daszuta A. Mechanisms Contributing to the Phase-Dependent Regulation of Neurogenesis by the Novel Antidepressant, Agomelatine, in the Adult Rat Hippocampus. Neuropsychopharmacology 2009, 34:2390-403. 10.1038/npp.2009.72, 19571795.
30. Molteni R, Calabrese F, Pisoni C, Gabriel C, Mocaer E, Racagni G, Riva MA. Synergic mechanisms in the modulation of the neurotrophin BDNF following acute agomelatine administration in the rat prefrontal cortex. The World J Biol Psychiatry 2010, 11:148-53.
31. Barbiero VS, Giambelli R, Musazzi L, Tiraboschi E, Tardito D, Perez J, Drago F, Racagni G, Popoli M. Chronic antidepressants induce redistribution and differential activation of αCaM kinase II between presynaptic compartments. Neuropsychopharmacol 2007, 32:2511-2519.
32. Dekeyne A, Mannoury la Cour C, Gobert A, Brocco M, Lejeune F, Serres F, Sharp T, Daszuta A, Soumier A, Papp M, Rivet JM, Flik G, Cremers TI, Muller O, Lavielle G, Millan MJ. S32006, a novel 5-HT2C receptor antagonist displaying broad-based antidepressant and anxiolytic propertie in rodent models. Psychopharmacology (Berl) 2008, 199:549-568. 10.1007/s00213-008-1177-9, 18523738.
33. Vollmayr B, Henn FA. Learned helplessness in the rat: improvements in validity and reliability. Brain Res Brain Res Protoc 2001, 8:1-7. 10.1016/S1385-299X(01)00067-8, 11522522.
34. Dunkley PR, Jarvie PE, Heath JW, Kidd GJ, Rostas JA. A rapid method for isolation of synaptosomes on Percoll gradients. Brain Res 1986, 372:115-129. 10.1016/0006-8993(86)91464-2, 3011205.
35. Raiteri M, Angelini F, Levi G. A simple apparatus for studying the release of neurotransmitters from synaptosomes. Eur J Pharmacol 1974, 25:411-414. 10.1016/0014-2999(74)90272-6, 4151269.
36. Raiteri M, Sala R, Fassio A, Rossetto O, Bonanno G. Entrapping of impermeant probes of different size into nonpermeabilized synaptosomes as a method to study presynaptic mechanisms. J Neurochem 2000, 74:423-431. 10.1046/j.1471-4159.2000.0740423.x, 10617148.